Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,933.00
Ask: 1,935.00
Change: 17.00 (0.89%)
Spread: 2.00 (0.103%)
Open: 1,922.00
High: 1,936.00
Low: 1,904.00
Prev. Close: 1,913.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish mixed as US GDP growth slows

Thu, 25th Apr 2024 15:14

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

The FTSE 100 finished up 0.48%, closing at 8,078.86 points, while the FTSE 250 slipped 0.6% to 19,601.98 points.

In currency markets, sterling was last up 0.22% on the dollar to trade at $1.2492, while it managed gains of 0.04% against the euro, changing hands at €1.1654.

"The FTSE 100 reached a new all-time high on Thursday, driven by a surge in miner Anglo American's stock following a buyout offer from BHP Group," said TickMill market analyst Patrick Munnelly.

"Additionally, investors were pleased with the strong financial results from several leading companies such as Unilever, AstraZeneca, and Barclays."

Munnelly noted that after BHP's announcement of a buyout offer for Anglo American, the London-listed miner's shares soared to their highest level in nine months.

"If successful, this deal would establish the world's largest copper miner, accounting for approximately 10% of global output.

"However, BHP's stock on the UK market experienced a decline in response to the news."

US GDP growth comes in slower than expected, UK retail sales decline

In economic news, activity in the United States faced a larger slowdown than expected at the start of the year, according to fresh data from the Department of Commerce.

Gross domestic product (GDP) grew at a quarterly annualised pace of 1.6%, down from the prior quarter's 3.4% rate and below the consensus forecast of 2.5%.

At the same time, the core price deflator for personal consumption expenditures increased to 3.7% from 2.0% in the prior quarter, indicating rising price pressures.

Factors contributing to the GDP slowdown included reduced consumption, increased imports, decreased inventory building, and a slowdown in public sector spending.

However, private domestic investment expanded 3.2%, a notable improvement from the previous quarter.

"As for the growth outlook, we expect to see more subdued activity in upcoming quarters," said James Knightley, chief international economist at ING.

"The divergence between business surveys and official data is very wide.

"We strongly suspect that business caution will translate into weaker hiring and wage growth and subdued business capex, and that will eventually show up in the official GDP data."

On home shores, the UK retail sector encountered an unexpected decline in sales in April, according to the Confederation of British Industry's (CBI) distributive trades survey.

The retail sales volumes gauge plummeted to -44 from 2 in March, accompanied by a decline in orders placed with suppliers to -49 from -22.

Retailers expressed pessimism regarding future sales and orders, with expectations of further declines in May, albeit at a slower pace.

The CBI attributed the surprise slump partly to the timing of Easter this year.

"April's sharp fall was likely related to the earlier timing of Easter this year, so we should take it with a pinch of salt," said Alpesh Paleja, CBI lead economist.

"Indeed, the sector is likely to benefit from some favourable tailwinds this year, as falling inflation continues to drive growth in households' real earnings

"That being said, conditions do remain challenging on the ground; April's fall in sales was faster than expected and retailers aren't overly hopeful about the month ahead.

On the continent, German consumer sentiment continued to strengthen, as indicated by the latest GfK consumer climate indicator.

Heading into May, the indicator rose to -24.2, the highest level in two years and surpassing forecasts for -25.9.

The improvement marked the third consecutive monthly rise.

Anglo American surges on BHP offer, ex-divs drag on the downside

On London's equity markets, Anglo American soared 16.1% following confirmation of an unsolicited takeover proposal from Australia's BHP Group.

The offer, worth £31.1bn, offered shareholders of the London-listed miner 0.7097 BHP shares for each Anglo share.

Elsewhere, AstraZeneca saw a notable uptick of 5.65% after reporting an 18% increase in first-quarter revenues, driven by robust sales of its cancer drugs, surpassing market expectations.

Barclays edged up 2.52%, despite a 12% decline in first-quarter profit, buoyed by slightly better-than-expected results.

Hikma Pharmaceuticals also made gains of 2.26%, driven by a strong performance across all business segments in 2024.

On the downside, J Sainsbury fell 4.25% despite the grocer surpassing earnings expectations for the year.

Trainline plummeted by 11.95%, coinciding with the Labour Party's pledge to renationalise Britain's railways if elected.

Online greeting cards and gift retailer Moonpig slid by 12.73% after a discounted share placement by certain shareholders.

WH Smith also experienced a sharp decline of 6.04%, despite expressing confidence in meeting full-year expectations, as its first-half results underwhelmed.

Legal & General Group, Greggs, Bakkavor Group, St James's Place, and Morgan Sindall Group all traded lower after going ex-dividend, affecting shareholder payouts.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 8,078.86 0.48%

FTSE 250 (MCX) 19,601.98 -0.60%

techMARK (TASX) 4,515.55 0.36%

FTSE 100 - Risers

Anglo American (AAL) 2,560.00p 16.10%

Barclays (BARC) 204.00p 6.73%

AstraZeneca (AZN) 12,026.00p 5.94%

Unilever (ULVR) 4,082.00p 5.67%

Antofagasta (ANTO) 2,227.00p 2.82%

Hikma Pharmaceuticals (HIK) 1,854.00p 2.26%

NATWEST GROUP (NWG) 289.80p 1.36%

Imperial Brands (IMB) 1,827.50p 1.27%

Marks & Spencer Group (MKS) 260.70p 1.12%

London Stock Exchange Group (LSEG) 8,890.00p 0.93%

FTSE 100 - Fallers

Legal & General Group (LGEN) 232.80p -6.36%

Schroders (SDR) 347.20p -5.45%

St James's Place (STJ) 421.00p -5.18%

Sainsbury (J) (SBRY) 256.60p -4.25%

Pershing Square Holdings Ltd NPV (PSH) 3,838.00p -3.91%

Convatec Group (CTEC) 275.60p -3.30%

Spirax-Sarco Engineering (SPX) 8,850.00p -3.28%

BAE Systems (BA.) 1,320.00p -3.19%

Prudential (PRU) 714.00p -2.88%

Rolls-Royce Holdings (RR.) 405.70p -2.71%

FTSE 250 - Risers

Inchcape (INCH) 786.50p 9.32%

Senior (SNR) 163.80p 2.37%

Drax Group (DRX) 524.00p 2.24%

Tritax Eurobox (GBP) (EBOX) 51.00p 2.19%

Hipgnosis Songs Fund Limited NPV (SONG) 103.60p 2.17%

Oxford Instruments (OXIG) 2,225.00p 2.06%

W.A.G Payment Solutions (WPS) 66.20p 1.85%

Hochschild Mining (HOC) 159.60p 1.79%

Ferrexpo (FXPO) 51.90p 1.76%

Bank of Georgia Group (BGEO) 5,290.00p 1.73%

FTSE 250 - Fallers

Moonpig Group (MOON) 155.00p -12.73%

Trainline (TRN) 302.00p -11.95%

Indivior (INDV) 1,400.00p -7.53%

Auction Technology Group (ATG) 493.00p -6.98%

Watches of Switzerland Group (WOSG) 334.20p -6.07%

WH Smith (SMWH) 1,182.00p -6.04%

Mobico Group (MCG) 52.85p -5.63%

Tyman (TYMN) 374.00p -4.83%

Bakkavor Group (BAKK) 117.50p -4.47%

FirstGroup (FGP) 163.70p -4.10%

More News
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.